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Background: Solanum anomalum Thonn. ex Schumach. (family Solanaceae) is a shrub with edible fruit consumed 
locally for nutritional and medicinal purposes. 
Objective: To evaluate the leaf extract of Solanum anomalum for analgesic properties in mice. 
Method: The ethanol leaf extract of Solanum anomalum (70-210 mg/kg) was evaluated for analgesic activity against 
nociception in mice using acetic acid-induced writhing, formalin-induced hind paw licking and thermally-induced pain 
models.  
Results: The leaf extract significantly inhibited nociception in all the models tested in a dose-dependent fashion.  
Conclusion: The leaf extract possesses analgesic activity which confirms its use in traditional medicine in the 
treatment of pains. 
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1. Introduction 
Solanum anomalum Thonn. ex Schumach. (family 
Solanaceae) is a shrub growing up to 2 metres tall. The 
stem, branches and midribs of the leaves have prickles 
up to 5 mm long. The edible fruits are gathered from the 
wild and consumed locally. Both the fruits and the 
leaves are used medicinally. The plant is sometimes 
cultivated or semi-cultivated for its fruits. It is found in 
West tropical Africa - Sierra Leone to southern Nigeria, 
Cameroon and DR Congo. It is known as 'childrens' 
tomatoes'. They are more commonly used as a 
condiment in soups and sauces and the fruits are eaten 
raw or cooked (Burkill, 2000). The sap from the leaves 
and fruits is drunk, or taken by enema 1 - 2 times daily, 
as a treatment for leprosy and gonorrhoea (Burkill, 
2000). The fruits are used as a laxative and digestive 
(Burkill, 2000). They are also served ground up in soups 
and sauces as an appetizer for sick persons, sometimes 
mixed with fruits of Parkia (Burkill, 2000). The crushed 
fruits are applied topically to promote maturation of 
inflamed parts of the fingers and toes (Burkill, 2000). 
The fruit juice is applied to sores on the ears to alleviate 
pain (Bukenya and Hall, 1988). Offor and Ubengama 
(2015) reported the antidiabetic activity of the fruit of 
this plant. The leaf extract has been reported to possess 
anti-inflammatory (Okokon et al, 2017), anticonvulsant 
and depressant (Okokon et al, 2019) activities. Although 
Solanum anomalum is used widely in traditional 
medicine for the treatment of various diseases, there is 
paucity of information on the biological activity of the 
leaves of this plant. We report in this study the analgesic 
activity of the leaf extract of the plant. 
2. Methods 
2.1 Plants collection and extraction 
The plant material Solanum anomalum (leaves) were 
collected in compounds in Uruan area, Akwa Ibom State, 
Nigeria in August, 2015. The plant was identified and 
authenticated by a taxonomist in the Department of 
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Botany and Ecological Studies, University of Uyo, Uyo, 
Nigeria. Hebarium specimen was deposited at 
Department of Pharmacognosy and Natural Medicine 
Herbarium (UUH: No 75 (a)).  
The plant parts (leaves) were washed and shade-dried 
for two weeks. The dried plants’ materials were 
reduced to powder using a mortar and pestle. The 
powdered material was macerated in 50% ethanol. The 
liquid filtrate was concentrated and evaporated to 
dryness in vacuo at 40˚C using rotary evaporator and 
stored in a refrigerator at - 4˚C.  
2.2 Phytochemical Screening  
Phytochemical screening of the crude extract was done 
employing standard procedures and tests (Trease and 
Evans, 1989; Sofowora, 1993). These were carried out 
to reveal the presence of chemical constituents such as 
alkaloids, flavonoids, tannins, terpenes, saponins, 
anthraquinones, reducing sugars, cardiac glycosides 
among others.  
2.3 Animal Husbandry 
Albino Swiss mice (19 – 28g) of either sex were 
obtained from the University of Uyo animal house. They 
were housed in standard cages with saw dust beddings 
and maintained on standard animal pellets (Guinea 
Feeds, Nigeria) and water ad libitum.  The animals were 
maintained under standard conditions (12 hours light/ 
12 hours dark cycle). Permission and approval for 
animal studies were obtained from the College of Health 
Sciences Animal Ethics committee, University of Uyo 
(CHS/AE/015/18). All experiments were carried out in 
accordance with the National Institute of Health 
Guidelines for the Care and Use of laboratory Animals 
(NIH Publications No. 80-23) revised in 2002. 
2.4 Determination of median lethal dose (LD50)  
The median lethal dose (LD50) of the extract was 
estimated using albino mice by intraperitoneal (i.p) 
route using the method of Lorke (1983). This involved 
intraperitoneal administration of different doses of the 
extract (100 -1000 mg/kg) to groups of three mice each. 
The animals were observed for manifestation of 
physical signs of toxicity such as writhing, decreased 
motor activity, decreased body/limb tone, decreased 
respiration and death. The number of deaths in each 
group within 24 hours was recorded. The LD50 was 
calculated as geometrical means of the maximum dose 
producing 0% (a) and the minimum dose producing 
100% mortality (b).  
2.5 Evaluation of analgesic potential of the extract 
Acetic acid induced writhing in mice 
Writhings (abdominal constrictions consisting of the 
contraction of abdominal muscles together with the 
stretching of hind limbs) resulting from intraperitoneal 
(i.p) injection of 2% acetic acid (Sigma, USA, Analar 
grade), was induced according to the procedure 
described by Santos et al, (1994), Correa et al, (1996) 
and Nwaforet al, (2010). The animals were divided into 
5 groups of 6 mice per group. Group 1 served as 
negative control and received 10 mL/kg of normal 
saline, while groups 2, 3 and 4 were pre-treated with 
70, 140, and 210 mg/kg doses of Solanum anomalum 
leaf extract intraperitoneally, and group 5 received100 
mg/kg of acetyl salicylic acid (Sigma, USA). After 30 
minutes, 0.2ml of 2% acetic acid was administered 
intraperitoneally (i.p). The number of writhing 
movements was counted for 30 minutes. Anti-
nociception (analgesia) was expressed as the reduction 
of the number of abdominal constrictions between 
control animals and mice pretreated with extracts. 
Formalin – induced hind paw licking in mice  
The procedure adopted was similar to that described by 
Hunskaar and Hole (1987), Correa and Calixto (1993), 
Gorki et al, (1993) and Okokon and Nwafor, (2010). The 
animals were injected with 20 μL of 2.5% formalin 
solution (0.9% formaldehyde) made up in phosphate 
buffer solution (PBS concentration: NaCl 137 mM, KCl 
2.7 mM and phosphate buffer, 10 mM) under the 
surface of the right hind paw. The amount of time spent 
licking the injected paw was timed and considered as 
the indication of pain. Adult albino mice (20 – 25 g) of 
either sex randomized into five groups of 6 mice each 
were used for the experiment. The mice were fasted for 
24 hours before being used but allowed access to water. 
The animals in group 1 (negative control) received 10 
mL/kg of normal saline, groups 2 - 4 received 70, 140, 
and 210 mg/kg doses of the extract, while group 5 
received 100 mg/kg of acetyl salicylic acid (ASA) 30 
minutes before being challenged with buffered 
formalin. The responses were measured for 30 mins 
after formalin injection. 
Thermally induced pain in mice 
The effect of the extract on hot plate induced pain was 
investigated in adult mice. The hot plate was used to 
measure the response latencies according to the 
method of Vaz et al, (1996) and Okokon and Nwafor, 
(2010). Adult albino mice (20 – 25 g) of either sex 
randomized into five groups of 6 mice each were used 
for the experiment. The mice were fasted for 24 hours 
before being used but allowed access to water. The 
animals in group 1 (negative control) received 10 
mL/kg of normal saline, groups 2 - 4 received 70, 140, 
and 210 mg/kg doses of the extract, while group 5 
received 100 mg/kg of acetyl salicylic acid (ASA) 30 
minutes before the experiment.  
In these experiments, the hot plate was maintained at 
45•±1˚C, each animal was placed into a glass beaker of 
50 cm diameter on the heated surface, and the time(s) 
between placement and shaking or licking of the paws 
or jumping was recorded as the index of response 
latency. An automatic 30-second cut off was used to 
prevent tissue damage.  
The animals were randomly divided into 5 groups of 6 
mice each and fasted for 24 hours but allowed access to 
water. Group 1animal served as negative control and 
received 10 mL/kg of normal saline. Groups 2, 3 and 4 
were pretreated intraperitoneally with 70, 140, and 210 
mg/kg doses of Solanum anomalum leaf extract 
respectively, while group 5 animals received 100 mg/kg 
of acetyl salicylic acid intraperitoneally, 30 minutes 
prior to the placement on the hot plate. 
Okokon et al, Afr. J. Pharmacol. Ther. 2020. 9(1): 22-26 
 
A KeSoBAP Publication ©2020. All rights reserved. 
24 
2.6 Statistical analysis and data evaluation  
Data obtained from this work were analyzed 
statistically using ANOVA (One- way) followed by a post 
test (Tukey-Kramer multiple comparison test). 
Differences between the means were considered 
significant at 1% and 5% level of significance i.e. p 
<0.05. Graphpad Instat 3 (USA) was used for the 
analyses.  
3. Results  
The phytochemical screening of the ethanol extract of 
the leaf of Solanum anomalum revealed the presence of 
alkaloids, cardiac glycosides, tannins, saponins, 
terpenes and flavonoids. 
The median lethal dose (LD50) was calculated to be 
724.5 mg/kg. The physical signs of toxicity included 
excitation, paw licking, increased respiratory rate, 
decreased motor activity, gasping and coma which was 
followed by death. 
The administration of Solanum anomalum extract (70-
210 mg/kg) demonstrated a dose-dependent reduction 
in acetic acid-induced writhing in mice. The reductions 
were statistically significant (p<0.05) relative to control 
and not comparable to that of the standard drug, ASA 
(Table 1).  
The extract exhibited a dose- dependent analgesic effect 
on formalin-induced hind paw licking in mice. The 
extract prominently inhibited the two phases of 
formalin-induced paw licking with a more considerable 
inhibition of the second phase. These inhibitions were 
significant when compared to the control (p< 0.05) and 
comparable to that of the standard drug, ASA (Table 2).  
 
Table 1: Effect of Solanum anomalum leaf extract on acetic acid induced writhing in mice. 
Dose  
(mg/kg) 
Time Intervals (hr) 
5 10 15 20 25 30 TOTAL 
Control 6.660.88 11.661.20 24.66 1.85 17.0 0.57 13.001.15 11.0 1.00 83.986.65 
Extract 
     70 
 
4.33 0.33 
 
5.331.45 
 
13.02.00 b 
 
12.660.88 b 
 
11.660.66 
 
7.66 0.33 
 
54.645.65a 
     140 3.33 0.33 5.33 2.96 9.001.52c 9.66  0.88c 8.331.76 7.01.00a 42.658.45c 
…..210 0.33 0.33c 3.000.57 b 4.331.20c 4.00 0.57c 5.660.88b 4.00 0.57c 21.324.12c 
ASA 100 4.000.57a 6.000.57 8.33 0.88c 8.66 0.33c 7.660.66c 4.00  0.57c 38.653.58c 
Data expressed as mean  SEM. significant at ap< 0.05,bp<  0.01, cp< 0.001 when compared to control n = 6. ASA: acetylsalicylic acid 
 
Table 2: Effect of Solanum anomalum leaf extract on formalin- induced hind paw licking in mice. 
Dose  
(mg/kg) 
Time Intervals (hr) 
5 10 15 20 25 30 TOTAL 
Control 24.330.33 22.370.66 20.660.44 14.330.23 13.03 0.14 10.160.16 104.881.96 
Extract 
     70 
 
4.33 0.33 
 
5.331.45 
 
13.02.00 B 
 
12.660.88 B 
 
11.660.66 
 
7.66 0.33 
 
54.645.65a 
     140 3.33 0.33 5.33 2.96 9.001.52c 9.66  0.88c 8.331.76 7.01.00a 42.658.45c 
…..210 0.33 0.33c 3.000.57 B 4.331.20c 4.00 0.57c 5.660.88b 4.00 0.57c 21.324.12c 
ASA 100 4.000.57a 6.000.57 8.33 0.88c 8.66 0.33c 7.660.66c 4.00  0.57c 38.653.58c 
Data expressed as mean  SEM. significant at ap< 0.05,bp<  0.01, cp< 0.001 when compared to control n = 6. ASA: acetylsalicylic acid 
 
Table 3: Effect of Solanum anomalum leaf extract on hot plate test 
Group 
Dose 
(mg/kg) 
Reaction time (sec) 
(mean  SEM) 
% inhibition 
Control - 4.92 0.23  
S. anomalum 70 5.97 0.22 21.3 
 140 13.25  0.50 a 169.3 
 210 20.51 0.74b 316.8 
ASA 100 29.533.48b 500.2 
Data expressed as mean  SEM.  Significant at ap< 0.05, b p< 0.001 when compared to control. n = 6. ASA: acetylsalicylic acid 
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The extract (70-210 mg/kg) exhibited a dose-
dependent effect on thermally-induced pain in mice. 
This inhibition was only statistically significant 
(p<0.001) when compared to the control at the highest 
dose of the extract. The effect of the extract was not 
comparable to that of the standard drug, ASA (Table 3). 
4.0 Discussion 
The extract significantly reduced acetic acid-induced 
writhing, formalin-induced hind paw licking and also 
delayed the reaction time of animals (mice) to thermally 
induced pain. Acetic acid causes inflammatory pain by 
increasing capillary permeability (Amico-Roxas et al, 
1984; Nwafor et al, 2007), and in part through local 
peritoneal receptors from peritoneal fluid 
concentration of PGE2 and PGF2α (Deraedt et al,1980; 
Bentley et al,1983). The acetic acid-induced abdominal 
writhing is a visceral pain model in which the processor 
releases arachidonic acid via cyclooxygenase, and 
prostaglandin biosynthesis plays a role in the 
nociceptive mechanism (Franzotti et al, 2002). It is used 
to distinguish between central and peripheral pain. 
These results suggest that the extract may be exerting 
its action partly through the lipoxygenase and/or 
cyclooxygenase system.  
The inhibition of acetic acid-induced writhing by the 
extract at all doses employed suggests an 
antinociceptive effect which might have resulted from 
decreased synthesis of arachidonic acid metabolites.  
Formalin- induced pains involve two different types of 
pains which are in phases; neurogenic and 
inflammatory pains (Vaz et al, 1996, 1997).This model 
measures both centrally and peripherally mediated 
activities that are characteristic of biphasic pain 
responses. The first phase (0 to 5 min), named 
neurogenic phase provoked the release of bradykinin 
and substance P while the second and late phase 
initiated after 15 to 30 min of formalin injection 
resulted in the release of inflammatory mediators such 
as histamine and prostaglandin (Wibool et al, 2008; Yi-
Yu et al, 2008). The first phase of formalin-induced hind 
paw licking is selective for centrally acting analgesics 
such as morphine (Berkenet al, 1991), while the late 
phase of formalin-induced hind paw licking is 
peripherally mediated. The extract ability to inhibit 
both phases of formalin-induced paw licking suggests 
its central and peripheral activities as well as its ability 
to inhibit bradykinins, substance P, histamine and 
prostaglandins which are mediators in these pains.  
It was observed that the extract significantly delayed 
the reaction time of the thermally- induced (hot plate) 
test. This model is selective for centrally acting 
analgesics and indicates narcotic involvement (Turner, 
1995) with opioid receptors.  
 Phytochemical screening of the leaf extract shows that 
the leaf extract contains alkaloids, flavonoids, cardiac 
glycosides, tannins, saponins, and terpenes (Okokon et 
al, 2017). Some of these phytoconstituents found to be 
present in the leaf extract of plant in this study may be 
responsible for the observed reported activity. 
Sesquiterpenes like β-caryophyllene and (E,E)-α-
farnesene have been reported to possess analgesic 
potentials (Ahmed et al, 1997;Chavanet al, 2012) and 
may also contribute to the observed analgesic activity. 
Flavonoids are known to act through inhibition of the 
cyclooxygenase and lipoxygenase pathways (Liang et al, 
1999; Carlo et al, 1999), phospholipase A2 and 
phospholipase C (Middleton et al, 2000). Some 
flavonoids exert their antinociception via opioid 
receptor activation activity (Suh et al, 1996; 
Rajendranet al, 2000; Otuki et al, 2005). The extract has 
been reported to exhibit analgesic activity. The 
presence of these compounds (polyphenolics, 
flavonoids, monoterpenes, sesquiterpenes and 
triterpenes) in this plant might account for the activity 
and may in part explain the mechanisms of its actions in 
this study.  
5.0 Conclusion  
The results of this study demonstrated that Solanum 
anomalum possesses analgesic properties which 
supports its use in traditional medicine for treatment of 
pain. 
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